Clinical Trial Update: PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical study called PRECISION-BP is investigating precision chronopharmacotherapy targeting the NP-RAAS-BP rhythm axis in obesity and cardio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Hypertension
• Obesity

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Obesity, Cardiovascular Diseases | Phase 2, Phase 3 | Status: RECRUITING